Mindfulness-based intervention is helpful to younger breast cancer survivors
the ONA take:
Researchers from the University of California in Los Angeles randomized younger women (50 years and younger) with early stage breast cancer who had completed cancer treatment to a 6-week Mindful Awareness Practices (MAPS) intervention group or to a wait-list control group.
Outcomes were assessed via questionnaires participants completed before and after the intervention. The results demonstrated that the MAPS intervention led to reductions in perceived stress, depressive symptoms, proinflammatory gene expression, and inflammatory signaling.
Improvements were also seen in secondary outcomes related to fatigue, sleep disturbance, and vasomotor symptoms.
However, the 3-month follow-up assessment revealed the effects on psychological and behavioral measures were not maintained. The authors conclude that brief, mindfulness-based intervention has short-term efficacy for younger breast cancer survivors.
Younger women with early stage breast cancer who had completed cancer treatment to a 6-week MAPS.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|